New Webinar: FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US - Drug Information Update

FDA is launching a webinar titled, “FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US”.
Dr. Sue Lim, M.D., Director of the Scientific Staff, Therapeutic Biologics and Biosimilars Team, CDER, FDA presents information on the regulation and development process of biosimilar and interchangeable products. This presentation was recorded to help FDA Advisory Committee members and Special Government Employees gain useful insight into the unique regulatory features and key concepts about biosimilarity and interchangeability.
To view this presentation visit our webinar, presentations, and articles page at www.fda.gov/biosimilars.